调节性T细胞与肾移植
本文综述调节性T细胞(Treg)在实体器官移植(包括肾移植)中的作用。Treg为CD4+细胞,高表达IL-2受体α链CD25及转录因子Foxp3,其应用旨在实现免疫耐受、减少或停用免疫抑制剂并维持组织修复和管理急性排斥。临床关键问题是如何有效扩增Treg数量,以及需克服Treg扩增、长期稳定性及脱靶非特异性免疫抑制(尤其癌症风险)等挑战。
要点
- Treg为CD4+CD25+Foxp3+细胞,参与移植耐受的主动过程。
- Treg治疗目标为减少或停用免疫抑制剂,同时维持组织修复和管理急性排斥。
- 临床挑战包括有效扩增Treg、长期稳定性及降低癌症等脱靶风险。
核心结论
- Treg在实体器官移植中用于实现耐受,以减少或停用免疫抑制剂并维持组织修复和管理急性排斥。
研究设计与样本
- 本文为综述,未报告系统检索范围或样本量。
主要发现
- Treg经典为CD4+细胞,组成性高表达IL-2受体α链CD25及转录因子Foxp3。
- 即使使用常规免疫抑制,同种异体移植物的接受是主动过程,常由Treg的存在决定。
- 临床使用Treg的关键问题是如何有效扩增Treg数量,可通过增加内源性Treg或直接输注外源性扩增的Treg。
临床怎么用
- Treg治疗旨在减少或停用免疫抑制剂,同时维持组织修复和管理急性排斥。
局限性
- 需确保Treg有效扩增、改善长期稳定性并降低与脱靶、非特异性免疫抑制(尤其癌症)相关的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The ability of the immune system to differentiate self from nonself is critical in determining the immune response to antigens expressed on transplanted tissue. Even with conventional immunosuppression, acceptance of the allograft is an active process often determined by the presence of regulatory T cells (Tregs). Tregs classically are CD4+ cells that constitutively express high levels of the IL-2 receptor α chain CD25, along with the transcription factor Foxp3. The use of Tregs in the field of solid organ transplantation is related specifically to the objective of achieving tolerance, with the goal of reducing or eliminating immunosuppressive drugs as well as maintaining tissue repair and managing acute rejection. A key issue in clinical use of Tregs is how to effectively expand the number of Tregs, either through increasing numbers of endogenous Tregs or by the direct infusion of exogenously expanded Tregs. In order to realize the benefits of Treg therapy in solid organ transplantation, a number of outstanding challenges need to be overcome, including assuring an effective expansion of Tregs, improving long-term Treg stability and reduction of risk-related to off-target, nonspecific, immunosuppressive effects related specially to cancer.
引用
- Martin-Moreno PL, Tripathi S, Chandraker A, et al. Regulatory T Cells and Kidney Transplantation. Clin J Am Soc Nephrol. 2018. PMID: 29789350. doi:10.2215/CJN.01750218
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。